Видео ютуба по тегу Syngene Q2Fy24

Jonathan Hunt - MD & CEO on Q2FY24 & First-half FY24 results #syngene #financialresults
Jonathan Hunt - MD & CEO on Q2FY24 & First-half FY24 results #syngene #financialresults
Syngene International Earnings Call for Q2FY24
Syngene International Earnings Call for Q2FY24
Sibaji Biswas - Our CFO on Q2FY24 & First-half FY24 results #syngene #financialresults
Sibaji Biswas - Our CFO on Q2FY24 & First-half FY24 results #syngene #financialresults
Syngene FY22 Highlights
Syngene FY22 Highlights
Strong Show From Syngene In Q2 | MD & CEO Jonathan Hunt | Business News
Strong Show From Syngene In Q2 | MD & CEO Jonathan Hunt | Business News
Syngene FY21 Highlights
Syngene FY21 Highlights
Syngene International Shares Drop The Most Since 2019 After Cutting Full Year Growth Guidance
Syngene International Shares Drop The Most Since 2019 After Cutting Full Year Growth Guidance
Q4 Review: Syngene's MD & CEO On Q4 Report Card & FY24 Focus Areas | BQ Prime
Q4 Review: Syngene's MD & CEO On Q4 Report Card & FY24 Focus Areas | BQ Prime
Syngene 30th Annual General Meeting- July 26, 2023
Syngene 30th Annual General Meeting- July 26, 2023
Science Exchange Syngene Interview with Kenneth Barr Head of Discovery Services
Science Exchange Syngene Interview with Kenneth Barr Head of Discovery Services
Syngene International Earnings Call for Q4FY20 and Full Year
Syngene International Earnings Call for Q4FY20 and Full Year
Syngene International Q3 Fineprint, Capex Focus & FY25 Growth Drivers | Jonathan Hunt
Syngene International Q3 Fineprint, Capex Focus & FY25 Growth Drivers | Jonathan Hunt
EXCLUSIVE | Jonathan Hunt, MD & CEO, Syngene International Shares Insights On Q1 Earning
EXCLUSIVE | Jonathan Hunt, MD & CEO, Syngene International Shares Insights On Q1 Earning
Q2 Review: Syngene International Beats Estimates
Q2 Review: Syngene International Beats Estimates